British Journal of Cancer

Journal Title

  • British Journal of Cancer

ISSN

  • E 1532-1827 | P 0007-0920

Publisher

  • Nature Publishing Group

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • ENGLAND

Aime & Scopes

  • The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research. It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention, diagnosis and treatment. BJC welcomes research across all cancer types and has a particular focus on: metastasis, microenvironment, immunology and immunotherapy, targeted and next-generation therapeutics, chemotherapy and radiotherapy, mechanisms of resistance, clinical trials, genomics, epigenomics and precision medicine, epidemiology, metabolism and state-of-the art diagnostic approaches. The British Journal of Cancer is owned by Cancer Research UK, the world’s leading cancer charity dedicated to saving lives through research. The journal is separated into six general categories: /// Clinical Studies /// Translational Therapeutics /// Molecular Diagnostics /// Genetics and Genomics /// Cellular and Molecular Biology /// Epidemiology

Article List

1 - 7 out of 7 results.

1

BROWSE